Permira, the UK based global investment firm, that provides long-term investments, has invested an undisclosed amount in PharmaCord, the US based provider of patient services for the pharmaceutical industry. Founder and Chief Executive Officer Nitin Sahney and the management team will continue to lead PharmaCord and will remain significant investors in the company alongside the Permira funds.
- Target – PharmaCord
- Buyer – Permira Advisers Holdings limited
- Seller – Shareholders
